Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Tomas, Pika"'
Autor:
Eva Kriegova, Regina Fillerova, Jiri Minarik, Jakub Savara, Jirina Manakova, Anna Petrackova, Martin Dihel, Jana Balcarkova, Petra Krhovska, Tomas Pika, Petr Gajdos, Marek Behalek, Michal Vasinek, Tomas Papajik
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Extramedullary disease (EMM) represents a rare, aggressive and mostly resistant phenotype of multiple myeloma (MM). EMM is frequently associated with high-risk cytogenetics, but their complex genomic architecture is largely unexplored. We us
Externí odkaz:
https://doaj.org/article/37daeaba58954dc38da078cfcf51a94f
Autor:
Jiri Minarik, Tomas Pika, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomas Jelinek, Ludek Pour, Petr Pavlicek, Martin Mistrik, Lucie Brozova, Petra Krhovska, Katerina Machalkova, Pavel Jindra, Ivan Spicka, Hana Plonkova, Martin Stork, Jaroslav Bacovsky, Lenka Capkova, Michal Sykora, Petr Kessler, Lukas Stejskal, Adriana Heindorfer, Jana Ullrychova, Tomas Skacel, Vladimir Maisnar, Roman Hajek
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background We have performed a head to head comparison of all-oral triplet combination of ixazomib, lenalidomide and dexamethasone (IRD) versus lenalidomide and dexamethasone (RD) in patients with relapsed and refractory multiple myeloma (RR
Externí odkaz:
https://doaj.org/article/f4b149c2be57476793d1f90b53292d39
Autor:
Martin Stork, Sabina Sevcikova, Tomas Jelinek, Jiri Minarik, Jakub Radocha, Tomas Pika, Lenka Pospisilova, Ivan Spicka, Jan Straub, Petr Pavlicek, Alexandra Jungova, Zdenka Knechtova, Viera Sandecka, Vladimir Maisnar, Roman Hajek, Ludek Pour
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2535 (2022)
In multiple myeloma (MM), malignant plasma cells infiltrate the bone marrow. In some cases, plasma cells migrate out of the bone marrow creating either para-skeletal plasmacytomas (PS) or infiltrating soft tissues as extramedullary plasmacytomas (EMD
Externí odkaz:
https://doaj.org/article/e364609dd50643da92cbb311d623a43f
Autor:
Jiri Minarik, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomas Jelinek, Tomas Pika, Ludek Pour, Petr Pavlicek, Lubica Harvanova, Lenka Pospisilova, Petra Krhovska, Denisa Novakova, Pavel Jindra, Ivan Spicka, Hana Plonkova, Martin Stork, Jaroslav Bacovsky, Vladimir Maisnar, Roman Hajek
Publikováno v:
Cancers, Vol 14, Iss 20, p 5165 (2022)
Background: We confirmed the benefit of addition of ixazomib to lenalidomide and dexamethasone in patients with relapsed and refractory multiple myeloma (RRMM) in unselected real-world population. We report the final analysis for overall survival (OS
Externí odkaz:
https://doaj.org/article/61e15198e39d4b7ea3ceb812c161aa48
Autor:
Jiri Minarik, Tomas Szotkowski, Jan Hrbek, Petra Krhovska, Eva Buriankova, Jitka Proskova, Tomas Pika, Jaroslav Bacovsky
Publikováno v:
Clinical Case Reports, Vol 9, Iss 8, Pp n/a-n/a (2021)
Abstract We present a rare extramedullary, bifocal, and hyposecretory manifestation of relapsed MM that could be mistaken for an infection. We stress the importance of complex evaluation including serum, urine, and bone marrow assessment and whole‐
Externí odkaz:
https://doaj.org/article/0d6806fc26e446739e9c3918962842a3
Autor:
Lucie Karafiatova, Tomas Pika
Publikováno v:
Biomedical Papers, Vol 161, Iss 2, Pp 117-127 (2017)
Amyloidosis is a heterogeneous group of diseases characterized by the deposition of amyloid. It is caused by extracellular deposition of insoluble fibrils with beta-pleated sheet configuration. The protein misfolding abnormalities result in amyloid f
Externí odkaz:
https://doaj.org/article/0a0c6059e9eb4200b8dd663d86b1458e
Autor:
Martin Stork, Ivan Spicka, Jakub Radocha, Jiri Minarik, Tomas Jelinek, Alexandra Jungova, Petr Pavlicek, Lenka Pospisilova, Frantisek Sedlak, Jan Straub, Tomas Pika, Zdenka Knechtova, Anna Fidrichova, Ivanna Boichuk, Sabina Sevcikova, Vladimir Maisnar, Roman Hajek, Ludek Pour
Publikováno v:
Annals of Hematology
We performed real world evidence (RWE) analysis of daratumumab, lenalidomide and dexamethasone (Dara-Rd) versus lenalidomide and dexamethasone (Rd) treatment in relapsed/refractory multiple myeloma patients (RRMM). In total, 240 RRMM patients were tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84d71d7e55cadb3d6c314ad8aec76958
https://is.muni.cz/publication/2278163
https://is.muni.cz/publication/2278163
Autor:
Petra Krhovska, Tomas Pika, Jitka Proskova, Jana Balcarkova, Jana Zapletalova, Jaroslav Bacovsky, Jiri Minarik
Publikováno v:
European Journal of Haematology. 109:75-82
Our aim was to correlate serum levels of selected markers of bone metabolism and bone marrow microenvironment to cytogenetic changes in patients with multiple myeloma (MM).We assed cytogenetic changes in 308 patients and correlated them with the foll
Autor:
Jiri Minarik, Petra Krhovska, Jan Hrbek, Tomas Pika, Jaroslav Bacovsky, Miroslav Herman, Vlastimil Scudla
Publikováno v:
Biomedical Papers, Vol 160, Iss 2, Pp 305-309 (2016)
Aims: We carried out a prospective study in order to identify the best imaging approach for patients with newly diagnosed multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS). Methods: We assessed the extent of myeloma
Externí odkaz:
https://doaj.org/article/d90de27d81ee456aa65d3b1275848c75
Autor:
Vlastimil Scudla, Pavel Lochman, Tomas Pika, Jiri Minarik, Jana Zapletalova, Jaroslav Bacovsky
Publikováno v:
Biomedical Papers, Vol 160, Iss 1, Pp 84-93 (2016)
Background and Aims: Advances in the diagnosis and treatment of multiple myeloma (MM), place increasing demands on accurate stratification of patients as the starting point for optimal individualized therapy. The present study focused on assessing th
Externí odkaz:
https://doaj.org/article/d2d5f54e74cb44229a36041238e1602d